Treatment of major depressive disorder in children and adolescents - Most selective serotonin reuptake inhibitors are no longer recommended

被引：24
|
作者：
Ramchandani, P [1 ]
机构：
[1] Univ Oxford, Warneford Hosp, Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford OX3 7JX, England
来源：
BRITISH MEDICAL JOURNAL | 2004年 / 328卷 / 7430期
关键词：
D O I：
10.1136/bmj.328.7430.3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [41] A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder
    Papakostas, G. I.
    Homberger, C. H.
    Fava, M.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (08) : 843 - 848
  • [42] POLYGENIC SCORE FOR CARDIOMETABOLIC AND PSYCHIATRIC PHENOTYPES PREDICT RESPONSE TO TREATMENT WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN MAJOR DEPRESSIVE DISORDER
    Baune, Bernhard
    Amare, Azmeraw
    Schubert, K. Oliver
    Biernacka, Joanna
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S512 - S513
  • [43] A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder
    Papakostas, George I.
    Nelson, J. Craig
    Kasper, Siegfried
    Moeller, Hans-Juergen
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (02) : 122 - 127
  • [44] SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND LONGITUDINAL GROWTH IN CHILDREN AND ADOLESCENTS
    Calarge, Chadi A.
    Mills, James
    Zemel, Babette
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S293 - S294
  • [45] Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder
    Papakostas, GI
    Petersen, TJ
    Nierenberg, AA
    Murakami, JL
    Alpert, JE
    Rosenbaum, JF
    Fava, M
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (02) : 217 - 221
  • [46] Evaluation of the effect of selective serotonin-reuptake inhibitors on lymphocyte subsets in patients with a major depressive disorder
    Eugenia Hernandez, Maria
    Martinez-Fong, Daniel
    Perez-Tapia, Mayra
    Estrada-Garcia, Iris
    Estrada-Parra, Sergio
    Pavon, Lenin
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 (02) : 88 - 95
  • [47] Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder
    Krupa, Anna J.
    Chrobak, Adrian A.
    Soltys, Zbigniew
    Dudek, Dominika
    Szewczyk, Bernadeta
    Siwek, Marcin
    PHARMACOLOGICAL REPORTS, 2024, 76 (05) : 1100 - 1113
  • [48] Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine and venlafaxine, in Korean patients with major depressive disorder
    Jung, Y. -E.
    Jun, T. -Y.
    Kim, K. -S.
    Bahk, W. -M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (07) : 437 - 443
  • [49] Use of selective scrotonin reuptake inhibitors for depressive children and adolescents
    Fegert, JM
    Herpertz-Dahlmann, B
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2004, 32 (02): : 74 - 75
  • [50] Adjunctive tianeptine for partial or nonresponders to selective serotonin reuptake inhibitor treatment in major depressive disorder
    Bahk, W. M.
    Jae, Y. M.
    Jon, D. I.
    Min, K. J.
    Paik, K. C.
    Yoon, B. H.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2011, 15 : 16 - 16
12345